Home » Topics » Regulatory » Patents

Patents
RSS

Bristol-Myers Squibb isolates and synthesizes hayumicin antitumor antibiotics

June 21, 1996

Antibody production-enhancing peptides described

June 21, 1996

Cyclolignan derivatives disclosed

June 21, 1996

Alpha-glucosidase inhibitors from Seikagaku Kogyo

June 21, 1996

Antifungal sordarin derivatives reported by Glaxo Wellcome

June 21, 1996

5alpha-reductase type 1 inhibitors from Merck & Co.

June 21, 1996

Further aldose reductase inhibitors from Sankyo

June 14, 1996

Aldose reductase and AGE inhibitors from Nissan Chem.

June 14, 1996

Antidiabetic agents reported by Boehringer Mannheim

June 14, 1996

5-HT4 agonists developed by Nisshin Flour Milling

June 14, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.